Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
Penumbra secured CE Mark approval for its THUNDERBOLT device, enabling the launch of its Computer Assisted Vacuum Thrombectomy (CAVT) technology in Europe. THUNDERBOLT is the only CAVT device available for stroke treatment in both Europe and the US, introducing modulated aspiration to improve clot removal speed and completeness.
Key figures
- Drug Name
- THUNDERBOLT
- Stroke mortality increase projection
- 50% between 2020 to 2050
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.